NKTX revenueFY2025$0
NKTX revenue was $0 for fiscal 2025 (ended Dec 31, 2025), compared with $0 in fiscal 2024.
For fiscal 2025 (ended Dec 31, 2025), Nkarta Inc. reported $0 of revenue and -$104.08M of net income.
NKTX revenue was $0 for fiscal 2025 (ended Dec 31, 2025), compared with $0 in fiscal 2024.
NKTX net income was -$33.33M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$21.71M a year earlier. For the full fiscal 2025 it was -$104.08M, compared with -$108.79M in fiscal 2024.
NKTX diluted EPS was -$0.45 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.29 a year earlier. For the full fiscal 2025 it was -$1.41, compared with -$1.60 in fiscal 2024.
NKTX free cash flow was -$27.08M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$18.70M a year earlier. For the full fiscal 2025 it was -$89.91M, compared with -$104.11M in fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | - | - | - | - | $115.0K |
| Research and development | $90.43M | $96.74M | $96.77M | $90.90M | $63.41M | $36.22M | $17.22M |
| Selling, general and admin | $31.57M | $31.45M | $34.88M | $28.06M | $23.02M | $15.29M | $5.25M |
| Operating income | -$122.00M | -$128.19M | -$131.65M | -$118.95M | -$86.43M | -$51.51M | -$22.35M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$104.08M | -$108.79M | -$117.50M | -$113.84M | -$86.08M | -$91.36M | -$21.08M |
| EPS, basic | -$1.41 | -$1.60 | -$2.40 | -$2.61 | -$2.62 | -$5.44 | -$14.41 |
| EPS, diluted | -$1.41 | -$1.60 | -$2.40 | -$2.61 | -$2.62 | -$5.44 | -$14.41 |
| Diluted shares | 74.0M | 67.9M | 49.0M | 43.6M | 32.9M | 16.8M | 1.5M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $39.63M | $27.87M | $31.04M | $37.49M | $60.82M | $96.69M | $20.61M |
| Short-term investments | $236.65M | $239.48M | $217.15M | $314.65M | $177.27M | $218.22M | $16.38M |
| Current assets | $282.51M | $273.34M | $253.07M | $360.69M | $245.78M | $318.83M | $37.47M |
| Total assets | $404.21M | $501.20M | $378.88M | $472.94M | $273.90M | $337.65M | $48.41M |
| Current liabilities | $22.27M | $18.92M | $23.33M | $22.05M | $12.94M | $8.83M | $8.16M |
| Total liabilities | $91.88M | $93.23M | $105.60M | $100.73M | $22.94M | $16.43M | $14.08M |
| Shareholders' equity | $312.32M | $407.98M | $273.29M | $372.21M | $250.97M | $321.22M | -$25.48M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$88.70M | -$99.70M | -$86.16M | -$57.00M | -$67.93M | -$43.51M | -$18.37M |
| Capital expenditures | $1.21M | $4.41M | $28.15M | $47.11M | $5.03M | $7.51M | $1.93M |
| Free cash flow | -$89.91M | -$104.11M | -$114.31M | -$104.11M | -$72.95M | -$51.02M | -$20.30M |
| Investing cash flow | $100.32M | -$129.56M | $79.02M | -$184.69M | $32.53M | -$210.08M | -$18.30M |
| Financing cash flow | $141.0K | $226.08M | $691.0K | $219.01M | $1.20M | $329.82M | $49.58M |
| Stock-based compensation | $8.56M | $16.73M | $17.20M | $16.86M | $14.46M | $6.75M | $947.0K |
| Depreciation and amortization | $9.20M | $9.20M | $5.90M | $2.60M | $1.80M | $800.0K | $400.0K |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Operating margin | - | - | - | - | - | - | -19433.9% |
| Net margin | - | - | - | - | - | - | -18327.0% |
| Free cash flow margin | - | - | - | - | - | - | -17647.8% |
| Return on equity | -33.3% | -26.7% | -43.0% | -30.6% | -34.3% | -28.4% | - |
| Return on assets | -25.8% | -21.7% | -31.0% | -24.1% | -31.4% | -27.1% | -43.5% |
| Current ratio | 12.69 | 14.45 | 10.85 | 16.36 | 18.99 | 36.10 | 4.59 |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $29.46M | $29.05M | $24.99M | $25.28M | $20.20M | $20.78M | $24.17M | $23.13M | $25.25M | $23.13M | $25.24M | $23.32M |
| Selling, general and admin | $6.31M | $14.08M | $5.89M | $5.68M | $7.09M | $6.41M | $12.39M | $7.80M | $8.54M | $7.58M | $7.53M | $7.86M |
| Operating income | -$35.78M | -$43.13M | -$30.88M | -$30.96M | -$27.29M | -$27.19M | -$36.56M | -$30.92M | -$33.79M | -$30.71M | -$32.76M | -$31.18M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$33.33M | -$40.37M | -$27.83M | -$27.41M | -$21.71M | -$22.98M | -$31.98M | -$25.93M | -$28.34M | -$24.99M | -$29.52M | -$27.75M |
| EPS, basic | -$0.45 | -$0.54 | -$0.37 | -$0.38 | -$0.29 | -$0.31 | -$0.43 | - | -$0.39 | -$0.34 | -$0.58 | -$0.57 |
| EPS, diluted | -$0.45 | -$0.54 | -$0.37 | -$0.38 | -$0.29 | -$0.31 | -$0.43 | - | -$0.39 | -$0.34 | -$0.58 | -$0.57 |
| Diluted shares | 74.6M | 74.5M | 74.3M | - | 74.0M | 74.0M | 73.9M | - | 73.6M | 73.5M | 50.7M | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $48.35M | $24.96M | $27.36M | $39.63M | $60.11M | $53.41M | $52.60M | $27.87M | $56.96M | $120.40M | $250.28M | $31.04M |
| Short-term investments | $108.25M | $157.81M | $203.07M | $236.65M | $222.22M | $236.27M | $212.91M | $239.48M | $226.09M | $204.42M | $187.11M | $217.15M |
| Current assets | $162.55M | $188.04M | $235.88M | $282.51M | $289.27M | $296.57M | $271.55M | $273.34M | $290.15M | $331.80M | $442.78M | $253.07M |
| Total assets | $308.46M | $337.64M | $372.07M | $404.21M | $427.24M | $448.31M | $470.61M | $501.20M | $532.03M | $554.09M | $576.94M | $378.88M |
| Current liabilities | $28.07M | $23.56M | $18.21M | $22.27M | $18.99M | $18.93M | $18.76M | $18.92M | $22.47M | $20.86M | $22.19M | $23.33M |
| Total liabilities | $92.71M | $89.91M | $86.21M | $91.88M | $89.34M | $90.64M | $91.80M | $93.23M | $101.16M | $100.90M | $103.28M | $105.60M |
| Shareholders' equity | $215.75M | $247.74M | $285.86M | $312.32M | $337.90M | $357.67M | $378.81M | $407.98M | $430.87M | $453.18M | $473.65M | $273.29M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$25.84M | -$24.22M | -$28.20M | -$21.65M | -$18.69M | -$18.75M | -$29.61M | -$24.75M | -$24.55M | -$21.89M | -$28.51M | -$23.35M |
| Capital expenditures | $1.25M | $183.0K | $413.0K | $560.0K | -$8.0K | $138.0K | $518.0K | $1.10M | $777.0K | $2.35M | $175.0K | $6.81M |
| Free cash flow | -$27.08M | -$24.41M | -$28.61M | -$22.21M | -$18.70M | -$18.89M | -$30.13M | -$25.85M | -$25.32M | -$24.25M | -$28.68M | -$30.16M |
| Investing cash flow | $49.09M | $21.15M | $15.91M | $1.10M | $25.39M | $19.49M | $54.34M | -$4.52M | -$38.90M | -$107.63M | $21.48M | $15.84M |
| Financing cash flow | $143.0K | $676.0K | $6.0K | $64.0K | $0 | $77.0K | $0 | $184.0K | $2.0K | -$368.0K | $226.27M | $295.0K |
| Stock-based compensation | $1.76M | $1.86M | $1.90M | $1.90M | $1.77M | $2.05M | $2.83M | $3.89M | $4.05M | $4.41M | $4.37M | $3.51M |
| Depreciation and amortization | $2.10M | $2.70M | $2.30M | $2.30M | $2.30M | $2.30M | $2.30M | $2.30M | $2.40M | $2.30M | $2.30M | $2.30M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 5.79 | 7.98 | 12.96 | 12.69 | 15.23 | 15.67 | 14.48 | 14.45 | 12.91 | 15.91 | 19.95 | 10.85 |
Source: XBRL data Nkarta Inc. files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| NKTX | $0 | - | -$104.08M | - | $114.0M |
| FATE | $4.75M | -33.4% | -$124.43M | -2619.6% | $235.2M |
| ALLO | $6.94M | +269.5% | -$174.46M | -2513.9% | $366.2M |
| IPSC | $109.16M | +1556.8% | -$9.58M | -8.8% | $327.7M |
| SANA | - | - | -$149.27M | - | $740.1M |
| CRBU | $9.44M | +1.6% | -$102.47M | -1085.0% | $45.2M |